Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-26T22:02:25.405Z Has data issue: false hasContentIssue false

Regulation of E-cadherin

Published online by Cambridge University Press:  05 April 2005

Z. Yang
Affiliation:
Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
H. Zhang
Affiliation:
Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
R. Kumar
Affiliation:
Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

Abstract

Numerous studies suggest that loss of E-cadherin is necessary to induce Epithelial–mesenchymal transition (EMT) and metastasis. Snail is a major contributor to EMTs. The Snail family of zinc-finger transcription factors interact with the E-cadherin promoter to repress transcription during EMT. The present article reviews the regulation of E-cadherin and discusses recent novel insights into the molecular basis in the process of EMT.

Type
Focus On
Copyright
2005 Cambridge University Press

E-cadherin (uvomorrulin), the founding member of the cadherin superfamily of calcium-dependent, transmembrane glycoproteins, plays a critical role in establishing adherens-type junctions. E-cadherin contains a prototypic extracellular domain that mediates homophilic protein–protein interactions in a zipper-like fashion. The intracellular domains of cadherins interact with several proteins collectively known as catenins. The resulting molecular complex binds to α-catenin and assembles other peripheral cytoplasmic proteins to connect E-cadherin to the actin cytoskeleton. E-cadherin plays an essential role in normal physiologic processes such as development, cell polarity, and tissue morphology [1], and in pathologic states such as epithelial–mesenchymal transition (EMT), a process usually accompanied by tumor dedifferentiation, infiltration, and metastasis. Alterations in E-cadherin expression or functions are common during carcinogenesis. In general, aberrant spatial–temporal expression or repression of E-cadherin is accompanied during EMT, an essential component of cancer progression to more aggressive phenotypes. In contrast, restoration of E-cadherin expression enhances intercellular adhesion, inhibits tumorigenicity, and suppresses the invasiveness of epithelial tumor cells [2,3]. Due to the loss of cell-to-cell junctions during EMT, E-cadherin loss leads to an increased pool of the cytoplasmic β-catenin as well as its transcription activity, resulting in the stimulation of β-catenin-responsive growth-regulatory genes [2]. Here we will briefly summarize the regulation of E-cadherin expression and discuss novel insights by which upstream regulators of E-cadherin might control the process of EMT, with a particular emphasis in breast cancer cells.

Genetic control of E-cadherin expression

The E-cadherin encoding gene, CDH1, maps to a region on chromosome 16q22.1, a region frequently associated with the loss of heterozygosity in sporadic breast cancers [4]. Since somatic mutations inactivating the CDH1 gene are found in over 50% of diffuse-type gastric and infiltrative lobular breast cancers [5], E-cadherin has been proposed to have a causal role in some human cancers. However, the finding that E-cadherin mutations are rare in ductal breast cancers [4] suggests the potential involvement of epigenetic modifications in controlling the functions of E-cadherin.

Epigenetic control of E-cadherin inactivation

Epigenetic mechanisms such as hypermethylation of the E-cadherin promoter [6,7], Histone H3 deacetylation (HDAC) in the context of CpG-methylation-mediated gene silencing [8], and transcriptional silencing have all been linked to the inactivation of E-cadherin expression. Analysis of somatic cell hybrids of E-cadherin-positive and -negative breast cancer cells suggests that the loss of E-cadherin expression in some breast cancers may be linked with a dominant repression transacting pathway [9], presumably due to dysregulation of transcription factors, support the notion of direct transcriptional silencing of E-cadherin as a major regulatory mechanism in human cancers.

Transcriptional controls of E-cadherin

The transcription of E-cadherin is controlled by both positive- and negative-regulatory elements located in its 5V promoter region [3,1012]. The V promoter region also contains three E-box motifs, and protein-binding motifs with a core consensus sequence of CANNTG [3,1317], which have both negative- and positive-regulatory functions. The E-box motifs function as negative regulators of E-cadherin in mesenchymal and in transformed cells by binding to Snail [3,1317] or Zeb [13]. In addition, the E-box motifs could also impart a positive-regulatory function in epithelial cells [12] due to interactions with bHLH transcription factors [14].

The demonstration that the Snail family of zinc-finger transcriptional repressors control E-cadherin expression in epithelial cells has opened a new avenue of research in the field EMT. Examples of zinc-finger transcription repressors of E-cadherin include: Snail, Slug, ZEB1 and SIP1 (ZEB2) [17], and Twist [18]. Two widely studied repressors of E-cadherin expression and consequently, of EMT, are Snail and Slug [3,14,15], with ectopic expression of Snail or Slug in epithelial cells downregulating E-cadherin and promoting fibroblastic, tumorigenic and invasive characteristics [3,14,15]. Snail also activates the transcription of vimentin and fibronectin, which are bona fide markers of mesenchymal differentiation. Accordingly, carcinoma cells with low or no E-cadherin contain high levels of Snail-1 [3,14,19,20]. In addition to cancer, Snail is also critical during developmental processes, as Snail-1 knockout mice were unable to undergo gastrulation and neural-crest EMT [16], and is embryonic lethal due to its inability to downregulate E-cadherin and undergo EMT [17].

Slug was first identified as another repressor of E-cadherin in chicken, where it was shown to be critical in the induction of EMT during embryonic development [21]. However, this function is not conserved in all vertebrates, as its expression does not correlate with the loss of E-cadherin expression or EMT during mouse embryogenesis [3,22], and unlike Snail, Slug-null mice are viable and fertile [22]. Interestingly, the status of Slug expression correlates well with the loss of E-cadherin in human breast carcinomas [15]. There is also evidence to suggest that Slug might participate in EMT via downregulation of the components of the desmosome adhesion complex [23], in addition to downregulation of E-cadherin in some epithelial cell lines in a specific cellular contexts.

Transcriptional repressor activity of Snail has been linked with the C-terminus zinc fingers which mediate the sequence specific DNA binding to the E-box consensus sequence of CANNTG [3,14,19,2328]. It is hypothesized that the repressor function of the Snail proteins is partially mediated via its competition with the bHLH transcription factors to bind the E-box motif [16,26]. Although the repressor activity depends greatly on the zinc-finger region, at least two other regions in the N-terminus are important for repressor function. The SNAG (Snail/Gfi) domain is conserved in the N-terminal region of all vertebrate Snail genes, and shown to be important for the repressor function of the Snail proteins in mammalian cells. Several vertebrate Snail family members also contain a partial CtBP interaction domain (CID) consensus sequence. The transcriptional repressor role of the Snail family of proteins is therefore mediated by its ability to compete for regulatory elements in the E-cadherin promoter, the SNAG domain, its interaction with CtBP, or a combination of the all three routes.

Cooperation of transcriptional repression with epigenetic modification

One widely accepted mechanism by which Snail represses the E-cadherin promoter includes the recruitment of repressor complexes involving Sin3A, or HDACs [9]. In addition, E-cadherin transcription is shown to be silenced by a CtBP corepressor complex containing different methylase and HDAC activities, as well as EF1 and SIP1 [19]. The complexity of repression of E-cadherin is further evident by the recent finding that the Snail gene is directly inhibited, in an HDAC-dependent manner, by MTA3, an estrogen-dependent component of the large transcriptional corepressor complex Mi-2/NuRD [2931]. In addition, corepressor function of Snail is also compromised by its subcellular relocalization to the cytoplasm [31,32]. Overall, these findings indicate that Snail regulation of E-cadherin might be regulated by the dynamic interplay among multiple coregulators in a temporal and spatial manner.

Signaling control of E-cadherin expression

The process of EMT as well as E-cadherin expression could be influenced by a variety of polypeptide growth factors and growth-factor-responsive signaling pathways. However, mechanisms by which signaling pathways regulates the expression of E-cadherin are poorly understood, but widely believed to involve modulation of the phosphorylation and/or the steady-state level of Snail [23]. For example, GSK-3β-mediated phosphorylation of Snail (at motif 2) negatively controls the stability of Snail protein, and thus, could lead to re-expression of E-cadherin in cells [32]. In contrast, stimulation of p21-activated kinase 1, a major signaling nodule downstream of growth factors and the Small GTPases, is required for an optimum transcription repression activity of Snail [33]. The underlying mechanism of Pak1 regulation of Snail activity involves Pak1 phosphorylation of Snail on serine 246 and its accumulation in the nucleus to exert its repressor functions [33]. Therefore, the corepressor functions of Snail and consequently, the process of EMT, could be modulated in both a negative and a positive manner depending on the nature of the signaling kinase activated or post-translational modification of Snail.

Future direction

Regulation of E-cadherin plays a crucial role in EMT and tumor progression. A hierarchy of different mechanisms at multiple levels, including genetic, epigenetic, and transcriptional regulations, may finally define the E-cadherin activity in a dynamic, as well as a cell and tissue specific manner. Since most of our current understanding of EMT in cancer cells is derived from tissue-culture model systems, it will be important to start combining these approaches with whole animal models as well as with human tumor specimens, to gain a comprehensive view of upstream regulators of E-cadherin that may be important in tumor invasion.

References

Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 1995; 7: 619627.Google Scholar
Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998; 392: 190193.Google Scholar
Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2: 7683.Google Scholar
Berx G, Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 2001; 3: 289293.Google Scholar
Hajra KM, Fearon ER. Cadherin and catenin alterations in human cancer. Gene Chromosom Cancer 2002; 34: 255268.Google Scholar
Strathdee G. Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin Cancer Biol 2002; 12: 373379.Google Scholar
Grady WM, Willis J, Guilford PJ, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 2000; 26: 1617.Google Scholar
Koizume S, Tachibana K, Sekiya T, Hirohashi S, Shiraishi M. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells. Nucleic Acids Res 2002; 30: 47704780.Google Scholar
Hajra KM, Ji X, Fearon ER. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene 1999; 18: 72747279.Google Scholar
Behrens J, Lowrick O, Klein-Hitpass L, Birchmeier W. The E-cadherin promoter: functional analysis of a GC-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci USA 1991; 88: 14951499.Google Scholar
Ringwald M, Baribault H, Schmidt C, Kemler R. The structure of the gene coding for the mouse cell adhesion molecule uvomorulin. Nucleic Acids Res 1991; 19: 65336539.Google Scholar
Giroldi LA, Bringuier PP, de Weijert M, Jansen C, van Bokhoven A, Schalken JA. Role of E boxes in the repression of E-cadherin expression. Biochem Biophys Res Commun 1997; 241: 453458.Google Scholar
Guaita S, Puig I, Franci C, et al. Snail induction of epithelial-to-mesenchymal transition in tumor cells is accompanied by MUC-1 repression and ZEB1 expression. J Biol Chem 2002; 277: 3920939216.Google Scholar
Batlle E, Sancho E, Franci C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2: 8489.Google Scholar
Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002; 62: 16131618.Google Scholar
Perez-Moreno MA, Locascio A, Rodrigo I, et al. A new role for E12/E47 in the repression of E-cadherin expression and epithelial–mesenchymal transitions. J Biol Chem 2001; 276: 2742427431.Google Scholar
Carver EA, Jiang R, Lan Y, Oram KF, Gridley T. The mouse snail gene encodes a key regulator of the epithelial–mesenchymal transition. Mol Cell Biol 2001; 21: 81848188.Google Scholar
Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927939.Google Scholar
Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002; 3: 155166.Google Scholar
Jiao W, Miyazaki K, Kitajima Y. Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br J Cancer 2002; 86: 98101.Google Scholar
Nieto MA, Sargent MG, Wilkinson DG, Cooke J. Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science 1994; 264: 835839.Google Scholar
Jiang R, Lan Y, Norton CR, Sundberg JP, Gridley T. The Slug gene is not essential for mesoderm or neural crest development in mice. Dev Biol 1998; 198: 277285.Google Scholar
LaBonne C, Bronner-Fraser M. Snail-related transcriptional repressors are required in Xenopus for both the induction of the neural crest and its subsequent migration. Dev Biol 2000; 221: 195205.Google Scholar
Fuse N, Hirose S, Hayashi S. Diploidy of Drosophila imaginal cells is maintained by a transcriptional repressor encoded by escargot. Genes Dev 1994; 8: 22702281.Google Scholar
Inukai T, Inoue A, Kurosawa H, et al. SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein. Mol Cell 1999; 4: 343352.Google Scholar
Kataoka H, Murayama T, Yokode M, et al. A novel snail-related transcription factor Smuc regulates basic helix-loop-helix transcription factor activities via specific E-box motifs. Nucleic Acids Res 2000; 28: 626633.Google Scholar
Fujiwara S, Corbo JC, Levine M. The snail repressor establishes a muscle/notochord boundary in the Ciona embryo. Development 1998; 125: 25112520.Google Scholar
Hemavathy K, Guru SC, Harris J, Chen JD, Ip YT. Human Slug is a repressor that localizes to sites of active transcription. Mol Cell Biol 2000; 20: 50875095.Google Scholar
Fujita N, Jaye DL, Kajita M, et al. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 2003; 113: 207219.Google Scholar
Kumar R. Another tie that binds the MTA family to breast cancer. Cell 2003; 113: 142143.Google Scholar
Mishra SK, Talukder AH, Gururaj AE, et al. Upstream determinants of estrogen receptor-alpha regulation of metastatic tumor antigen 3 pathway. J Biol Chem 2004; 279: 3270932715.Google Scholar
Zhou BP, Deng J, Xia W, et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004; 6: 931940.Google Scholar
Yang Z, Rayala S, Nguyen D, et al. Pak1 phosphorylation of Snail, a master regulator of epithelial-to-mesenchyme transition, modulates Snail's subcellular localization and functions. Cancer Res 2005; 65 (8) (in press).Google Scholar